Atalanta Therapeutics
PrivateLast Round
Series B
Jan 28, 2025
Total Funding Raised
$207M
Momentum Score
25 /100
Company Overview
Atalanta Therapeutics is a biotechnology company focused on developing RNA interference therapeutics aimed at treating neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atalanta Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Atalanta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2025 | ||||
| Series A | Jan 11, 2021 |
Key People
Founding team and executive leadership
Atalanta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series B |
| EQT Ventures | Series B |
| Mirae Asset | Series B |
| abrdn Inc. | Series B |
| F-Prime Capital | Series B, Series A |
| Genentech | Series A |
| GHR Foundation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2025
Alicia Secor stepped down as Chief Executive Officer.
- Jun 18, 2025
Joanne Kotz appointed as new Chief Executive Officer.
Atalanta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atalanta Therapeutics's valuation, stock price, and market status.
